In February 2020, the weight loss drug Belviq was removed from the market, amid concerns that side effects may increase the risk of cancer. Lawsuits and class action claims are now being pursued by former users throughout the United States.…
Belviq cancer concerns arose before the weight loss drug was even approved, but it never carried a cancer warning label.…
The first Zantac MDL conference is scheduled for March 20 to begin pretrial proceedings over claims that NDMA in the recalled heartburn drugs can cause cancer.…
A Zantac lawsuit claims the recalled heartburn drug contains NDMA, a chemical which led to the plaintiff developing pancreatic cancer.…
Side effects of Onglyza, a popular diabetes drug, may increase the risk of serious and potentially life-threatening injuries, including heart failure and pancreatic cancer. …
The first bellwether trials for reinstated Byetta, Victoza, pancreatitis lawsuits are not likely to begin before late 2020.…
A wrongful death lawsuit claims recalled generic valsartan tablets containing manufacturing impurities caused a man’s lethal case of pancreatic cancer.…
A generic valsartan lawsuit blames recalled tablets for the development of lung cancer and pancreatic cancer in a Kentucky man.…
A Viberzi lawsuit filed by a New York woman claims the IBS drug caused acute pancreatitis and left her at increased risk of pancreatic cancer.…
A new study suggests Victoza works as a diabetes drug for children, but is linked to an increased risk of stomach problems.…
